Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · IEX Real-Time Price · USD
21.77
-0.01 (-0.05%)
Jul 6, 2022 9:48 AM EDT - Market open
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 |
|---|---|---|---|
| Revenue
|
19.14 | 0 | 0 |
| Cost of Revenue
|
1.9 | 0 | 0 |
| Gross Profit
|
17.24 | 0 | 0 |
| Selling, General & Admin
|
59.22 | 22.69 | 11.75 |
| Research & Development
|
131.43 | 81.61 | 42.99 |
| Operating Expenses
|
190.65 | 104.3 | 54.74 |
| Operating Income
|
-173.41 | -104.3 | -54.74 |
| Interest Expense / Income
|
17.59 | 0.34 | 0 |
| Other Expense / Income
|
-107.05 | -1.37 | -2.21 |
| Pretax Income
|
-83.95 | -103.26 | -52.53 |
| Income Tax
|
0.04 | 0.01 | 0.02 |
| Net Income
|
-83.99 | -103.27 | -52.55 |
| Net Income Common
|
-83.99 | -103.27 | -52.55 |
| Shares Outstanding (Basic)
|
30 | 25 | 11 |
| Shares Outstanding (Diluted)
|
30 | 25 | 11 |
| Shares Change
|
20.08% | 119.84% | - |
| EPS (Basic)
|
-2.77 | -4.09 | -4.58 |
| EPS (Diluted)
|
-2.77 | -4.09 | -4.58 |
| Free Cash Flow Per Share
|
-1.44 | -3.54 | -3.45 |
| Gross Margin
|
90.06% | - | - |
| Operating Margin
|
-906.12% | - | - |
| Profit Margin
|
-438.86% | - | - |
| Free Cash Flow Margin
|
-228.77% | - | - |
| Effective Tax Rate
|
-0.04% | -0.01% | -0.04% |
| EBITDA
|
-65.39 | -102.31 | -52.21 |
| EBITDA Margin
|
-341.65% | - | - |
| Depreciation & Amortization
|
0.98 | 0.62 | 0.32 |
| EBIT
|
-66.36 | -102.93 | -52.53 |
| EBIT Margin
|
-346.75% | - | - |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).